SCHEMBL3755595

SCHEMBL3755595

Oc1ccc(O)c(C23CC4CC(CC(C4)C2)C3)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
POLB P06746 1/20 0.55
GAA P10253 1/20 0.55
GFER P55789 1/20 0.55
RARB P10826 5/20 0.52
RARA P10276 5/20 0.52
RARG P13631 4/20 0.52
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
TP53 P04637 1/20 0.51
CYP3A4 P08684 1/20 0.51
MAPT P10636 1/20 0.51
HPGD P15428 1/20 0.51
ALOX15 P16050 1/20 0.51
ALOX12 P18054 1/20 0.51
MAPK1 P28482 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HSD17B10 Q99714 1/20 0.51
ALOX5AP P20292 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3749653 0.89 MEN1 (0.47) MEN1KMT2APOLBGAAGFER
SCHEMBL11084834 0.85 ALOX5AP (0.49) MEN1KMT2APOLBGAAGFER
SCHEMBL3764016 0.85 ALOX5AP (0.45) MEN1KMT2APOLBGAAGFER
SCHEMBL2420330 0.85 MEN1 (0.50) MEN1KMT2APOLBGAAGFER
SCHEMBL549446 0.83 MEN1 (0.73) MEN1KMT2APOLBGAAGFER
SCHEMBL27829414 0.81 MEN1 (0.46) MEN1KMT2APOLBGAAGFER
SCHEMBL8766363 0.81 MEN1 (0.43) MEN1KMT2APOLBGAAGFER
SCHEMBL24259966 0.81 ALDH1A1 (0.52) MEN1KMT2APOLBGAAGFER
SCHEMBL566145 0.81 MEN1 (0.51) MEN1KMT2APOLBGAAGFER
SCHEMBL22321006 0.81 MEN1 (0.51) MEN1KMT2APOLBGAAGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104004187-B Polyimide having side chain group and method for producing same 欣兴电子股份有限公司 2016-06-08 CN disclosed
US-20150266806-A1 MANUFACTURING METHOD OF DIAMINE MONOMER WITH SIDE CHAIN UNIMICRON TECHNOLOGY CORP (TW) 2015-09-24 US disclosed
US-9074051-B2 Dianhydride monomer having side chain, polyimide compound having side chain and manufacturing method thereof UNIMICRON TECHNOLOGY CORP. (TW) 2015-07-07 US disclosed
US-9045597-B2 Polyimide compound having side chain and manufacturing method thereof UNIMICRON TECHNOLOGY CORP. (TW) 2015-06-02 US disclosed
US-20140275440-A1 DIAMINE MONOMER HAVING SIDE CHAIN, POLYIMIDE COMPOUND HAVING SIDE CHAIN AND MANUFACTURING METHOD THEREOF UNIMICRON TECHNOLOGY CORP. (TW) 2014-09-18 US disclosed
US-20140275441-A1 POLYIMIDE COMPOUND HAVING SIDE CHAIN AND MANUFACTURING METHOD THEREOF UNIMICRON TECHNOLOGY CORP. (TW) 2014-09-18 US disclosed
US-20140275470-A1 DIANHYDRIDE MONOMER HAVING SIDE CHAIN, POLYIMIDE COMPOUND HAVING SIDE CHAIN AND MANUFACTURING METHOD THEREOF UNIMICRON TECHNOLOGY CORP. (TW) 2014-09-18 US disclosed
US-8084650-B2 Adamantane derivative, resin composition containing same, and optoelectronic member and sealing agent for electronic circuit using those IDEMITSU KOSAN CO., LTD. (JP) 2011-12-27 US disclosed
US-20100298491-A1 ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC MEMBER AND SEALING AGENT FOR ELECTRONIC CIRCUIT USING THOSE IDEMITSU KOSAN CO., LTD. (JP) 2010-11-25 US disclosed
CN-101547885-A Adamantane derivative, process for producing the same, and resin composition containing adamantane derivative IDEMITSU KOSAN CO (JP) 2009-09-30 CN disclosed
EP-1985616-A1 ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC MEMBER AND SEALING AGENT FOR ELECTRONIC CIRCUIT USING THOSE Idemitsu Kosan Co., Ltd. (JP) 2008-10-29 EP disclosed
CN-1117966-A Biphenyl derivatives EISAI CO LTD (JP) 1996-03-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298491-A1 ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC MEMBER AND SEALING AGENT FOR ELECTRONIC CIRCUIT USING THOSE AOC1, ASIC1, ICAM1 MEN1 2523/4885KMT2A 4159/4885POLB 2866/4885
US-20140275470-A1 DIANHYDRIDE MONOMER HAVING SIDE CHAIN, POLYIMIDE COMPOUND HAVING SIDE CHAIN AND MANUFACTURING METHOD THEREOF POLL, APP, ASPH MEN1 1227/4885KMT2A 3087/4885POLB 383/4885
US-20140275440-A1 DIAMINE MONOMER HAVING SIDE CHAIN, POLYIMIDE COMPOUND HAVING SIDE CHAIN AND MANUFACTURING METHOD THEREOF POLL, DDC, DDT MEN1 1411/4885KMT2A 1008/4885POLB 113/4885
US-20150266806-A1 MANUFACTURING METHOD OF DIAMINE MONOMER WITH SIDE CHAIN POLL, DDT, DDC MEN1 1950/4885KMT2A 1928/4885POLB 140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.